Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Poly(rC)-binding protein 3 (PCBP3) is a member of the KH domain protein subfamily, also called alpha-CPs, which bind specifically to C-rich sequences in RNA. Unlike other alpha-CPs, PCBP3 is mainly cytoplasmic and lacks typical nuclear localization signals. It is involved in various post-transcriptional processes, such as regulation of gene expression via RNA binding, and is encoded by the *PCBP3* gene on human chromosome 21. Alternative splicing of the gene produces several transcript variants encoding distinct isoforms. Its specific cellular roles and clinical implications remain under-studied, though a genetic association with dementia has been noted. No drugs, targeted mechanisms of action, or known biomarker/safety concerns are currently reported for PCBP3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poly(rC)-binding protein 3 (PCBP3).